Archives
-
Ko 143 and BCRP Evidence in Drug Transport Research
2026-10-09
A source-grounded overview of Ko 143 as a BCRP inhibitor, its research context in multidrug resistance and pharmacokinetics, and how its supplier-reported properties compare with findings from a 2026 quercetin and PEG 400 study.
-
EZ Cap™ SaCas9 mRNA for Lung Editing Research
2026-10-08
Explore how EZ Cap™ SaCas9 mRNA fits into transient CRISPR-Cas9 research and why lung-targeted lipid nanoparticles matter for delivery. This evidence-focused guide connects the R1127 payload concept with recent findings on selective pulmonary LNPs while clearly separating demonstrated results from future applications.
-
In Vivo CD19 CAR T Cells for Lupus: Five Questions
2026-10-08
A source-grounded overview of the principles, findings, evidence quality, interpretation, scope, and limitations of an in vivo CD19 CAR T-cell study in a mouse model of systemic lupus erythematosus.
-
5-Methyl-CTP and the Next mRNA Translation Bottleneck
2026-10-07
5-Methyl-CTP offers a rational way to study how RNA chemistry influences transcript persistence and protein output. This thought-leadership analysis connects the 5-methyl modified cytidine triphosphate to delivery research, including an outer membrane vesicle platform reported for personalized tumor vaccination, while separating established findings from translational hypotheses.
-
Jasplakinolide in Actin Cytoskeleton Research
2026-10-07
Jasplakinolide is a widely used actin polymerization inducer and F-actin stabilizer, but its research value depends on separating direct biochemical evidence from supplier claims and downstream cellular phenotypes. This overview compares the available evidence, explains conceptual applications, and clarifies why bestatin research on plant jasmonate signaling should not be treated as evidence about jasplakinolide.
-
FLCN Mutations and mRNA Rescue in BHD Syndrome
2026-10-06
A 2026 study identified two rare FLCN variants in Chinese families with Birt-Hogg-Dubé syndrome and supplied genetic and functional evidence supporting pathogenicity. Its cell-based mRNA experiments provide an early proof of concept for restoring folliculin expression, but the findings remain preclinical and require validation in broader cohorts and disease-relevant models.
-
Palmitic Acid (N2456): Product Overview
2026-10-06
Palmitic acid (hexadecanoic acid; CAS 57-10-3) is a cataloged saturated long-chain fatty acid supplied by APExBIO for conceptual research relating to lipid metabolism and cellular signaling. No matched paper evidence was provided, so product identity should not be interpreted as validated experimental performance.
-
IMP and APEX-RNA-MS: Evidence Boundaries
2026-10-05
APEX-RNA-MS profiles RNA modifications near defined protein neighborhoods, including stress granules, P-bodies, and DNA damage foci. The supplied IMP dossier does not establish a product identity or mechanism, so biological claims about M1405 require additional authoritative product documentation.
-
IMP and Spatial RNA Modification Profiling
2026-10-05
IMP is cataloged as SKU M1405, but the supplied dossier does not define its chemical identity or mechanism. The cited APEX-RNA-MS study instead provides a spatial framework for measuring RNA modifications near proteins in stress granules, P-bodies, and DNA damage foci.
-
Guanabenz Acetate and GADD34 Signaling
2026-10-04
Guanabenz Acetate is examined here as a receptor-defined tool for studying adrenergic control of stress and innate immune signaling. This article connects α2-adrenergic pharmacology with the GADD34–IRF3 mechanism reported in SARS-CoV-2 research while clearly separating evidence from hypothesis.
-
APEX-RNA-MS and Spatial RNA Modification Biology
2026-10-03
APEX-RNA-MS combines proximity labeling with nucleoside mass spectrometry to examine RNA modifications near proteins in dynamic cellular structures. The supplied study reports modified-RNA signatures near DNA damage foci, stress granules, and P-bodies, while finding that multiple tRNAs accumulate near G3BP1 during stress-granule formation. These findings support a spatial view of RNA regulation, but the method measures protein-proximal modification patterns rather than proving direct RNA membership, molecular causality, or modification-specific function. The supplied article is identified as an in-press 2026 report, so its provenance and publication status should be considered when evaluating the evidence.
-
FXR–KLF11 Axis in Contrast-Induced AKI
2026-10-02
The reference study identifies an FXR–KLF11 transcriptional pathway through which Chenodeoxycholic Acid reduces contrast-induced acute kidney injury and suppresses JAK2/STAT3 signaling. Its combination of RNA sequencing, promoter validation, cell experiments, and genetic loss-of-function analysis provides a mechanistic framework for studying nuclear receptor signaling in renal injury.
-
Quantifying Methylated Purine Nucleosides by UHPLC–MS/MS
2026-10-01
The 2024 Analytical Chemistry study developed a stable isotope-diluted UHPLC–ESI–MS/MS workflow for accurate measurement of 12 purine ribonucleosides, including 10 methylated species. Its combination of ammonium bicarbonate-enhanced ionization, chromatographic isomer separation, methanol extraction, and solid-phase cleanup improves sensitivity in cell metabolite analysis and supports more rigorous purine metabolism studies.
-
Stable-Isotope UHPLC–MS/MS for Methylated Purines
2026-10-01
Zhang, Zhang, and Wang developed a stable isotope-diluted UHPLC–ESI-MS/MS workflow that improves the sensitivity, selectivity, and quantitative reliability of methylated purine nucleoside measurements. Ammonium bicarbonate-assisted ionization, chromatographic isomer resolution, methanol extraction, and solid-phase extraction enabled sensitive analysis of endogenous modified nucleosides in cultured cells.
-
3D-Printed TCP Scaffolds for Local EGCG Delivery
2026-09-30
This study developed three-dimensional printed tricalcium phosphate scaffolds that release EGCG locally while supporting osteogenic, vascular, anti-osteoclastogenic, and tumor-suppressive responses in vitro. Its main practical implication is a multifunctional scaffold concept for low-load-bearing craniofacial defects after trauma or tumor excision, although the findings remain preclinical.